Skip to Main Content

Paper Details

An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System.
Drug Saf
9
2020
Author NameAffiliation
Gerald J Dal PanCenter for Drug Evaluation and Research
  • 1 - 1

Datasets

Release 1.2